Reporting owner · CIK 0001598549

Schwab Andrew J.

Visual SEC Form 4 history across 2 companies, 16 transactions and 6 filings.

DIRCamp4 Therapeutics Corp
Open-market mix
Latest filingAug 31, 2026, 09:05 PM
Filings6Form 4 records
Buying$00 purchases
Selling$2.6M14 sales
Net value−$2.6MBuys minus sells
Companies22 securities
Most recentAug 27, 2026sale

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1580-8-15Feb 25Feb 2614Aug 26

Net value flow

Buys minus sells

Feb 25
$0
Feb 26
$0
Aug 26
−$2.6M

Transaction texture

Ownership and ticket size

Average P/S size$188.3K
Median P/S size$10.4K
Direct2
Indirect14
Aug 27, 2026sale

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern14Derivative Transactionfiling-context2Direct Ownershipfiling-context2Large Holdings Increaseholdings2Large Salesize2Repeat Sellerpattern11

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Camp4 Therapeutics Corp on Aug 27, 2026 valued at $1,616,000.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Latest sale

sale at Camp4 Therapeutics Corp on Aug 27, 2026 valued at $1,616,000.

Review SEC filing

Associated companies

Visual map of known reporting history

CAMPCamp4 Therapeutics Corp5 transactions · latest Aug 31, 2026, 09:05 PMSKYESkye Bioscience, Inc.11 transactions · latest Aug 20, 2026, 09:59 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
CAMPSchwab Andrew J.
DIR
sale400k-$161MS
Cluster Selling Large Sale Repeat Seller
0.0%08/3108/27
CAMPSchwab Andrew J.
DIR
sale10-$4.50kS
Cluster Selling Repeat Seller
—08/2608/24
CAMPSchwab Andrew J.
DIR
sale32.0k-$14.4MS
Cluster Selling Repeat Seller
−7.4%08/2108/21
CAMPSchwab Andrew J.
DIR
sale114k-$52.0MS
Cluster Selling Repeat Seller
−7.4%08/2108/20
CAMPSchwab Andrew J.
DIR
sale45.1k-$21.4MS
Cluster Selling
−7.4%08/2108/19
SKYESchwab Andrew J.
DIR
sale6.49k-$207kS
Cluster Selling Repeat Seller
+542.9%08/2008/20
SKYESchwab Andrew J.
DIR
sale46-$1.47kS
Cluster Selling Repeat Seller
+542.9%08/2008/20
SKYESchwab Andrew J.
DIR
sale1.15k-$37.0kS
Cluster Selling Repeat Seller
+542.9%08/2008/20
SKYESchwab Andrew J.
DIR
sale57.4k-$2.01MS
Cluster Selling Large Sale Repeat Seller
+542.9%08/2008/19
SKYESchwab Andrew J.
DIR
sale409-$14.3kS
Cluster Selling Repeat Seller
+542.9%08/2008/19

Schwab Andrew J. Insider Activity FAQ

SEC Form 4 context

Who is Schwab Andrew J.?

Schwab Andrew J. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001598549.

Which companies has Schwab Andrew J. reported transactions for?

Camp4 Therapeutics Corp, Skye Bioscience, Inc.

When was Schwab Andrew J.'s latest insider buy?

No open-market insider purchase is available for this period.

When was Schwab Andrew J.'s latest insider sale?

sale at Camp4 Therapeutics Corp on Aug 27, 2026 valued at $1,616,000.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.